Drug Approval | July 05, 2023
Zydus receives final approval from the USFDA for Oxcarbazepine Tablets
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
Cyanocobalamin Nasal Spray (RLD Nascobal) had estimated annual sales of USD 69 million in the U.S. (IQVIA MAT Mar 2023)
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Lupin has received US$ 25 million from AbbVie for initiation of Phase 1 clinical studies successfully
The company is already marketing the 4 mg and 10 mg strengths
Subscribe To Our Newsletter & Stay Updated
